11月10日周一盘中，港股上市公司雍禾医疗（02279）股价大跌5%，延续了近期的下跌趋势。尽管公司上半年业绩出现转机，但投资者信心似乎仍未恢复。
根据雍禾医疗2025年中期报告，公司上半年实现盈利2785.5万元，扭转了去年同期1.39亿元的亏损。然而，这一业绩改善主要源于成本控制和费用缩减，而非业务实质性增长。公司营业收入为8.62亿元，同比下降4.22%，其中核心的植发业务虽然服务人数增加，但人均消费下降，导致收入下滑。
值得注意的是，雍禾医疗近期面临多重挑战。公司自2024年以来累计收到13张行政处罚罚单，涉及医疗安全等问题。同时，消费者投诉频繁，涉及产品质量和合同纠纷等方面。这些负面因素可能影响了投资者对公司长期发展的信心，导致股价持续承压。尽管公司通过降低营销支出、优化门店结构等措施实现短期盈利，但市场似乎对其可持续增长能力仍持谨慎态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.